|
Mumbai, New Delhi, Hyderabad, Oct 23: crore for the same quarter last fiscal. For the six months ended September 30, 2008, total sales rose to Rs 158.51 crore against Rs 131.30 crore during the same period last fiscal.
Dabur Pharma posts loss in Q2
Dabur Pharma, the anti-cancer pharma company posted a loss of Rs 37.02 crore in the quarter ended September 30 as against a profit of Rs 8.54 crore in the corresponding quarter last year. The company said that during the quarter Fresenius SE, Singapore, acquired 90.89% control of the Dabur pharma requiring a one-time payment of Rs 27.19 crore to employees against their uninvested stock options.
Sterlite Industries Q2 net up 9%
Vedanta Group firm Sterlite Industries said its consolidated net profit for the July-September quarter increased by 9.34% to Rs 1,720.81 crore from over the corresponding period a year ago.
The total income rose to Rs 6,810.99 crore in the quarter under review, from Rs 6,613.15 crore in the same period last fiscal, Sterlite Industries said in a filing to the Bombay Stock Exchange.
NRI billionaire Anil Agarwal-led company had last month called off its corporate restructuring plan on melting market condition and adverse investor feedback. However, it maintained that it will stick to its over $9 billion expansion plan.
The company, which had made about $2.6 billion bid for the US-based metal producer Asarco, has also asked the American firm to revisit the purchase price in the light of changing dynamics of the global financial market.
On the standalone basis, leading copper producer witnessed an over two-fold jump in the net profit at Rs 462.93 crore in the September quarter, from Rs 212.87 crore in the same period previous year.
The company's standalone income increased to Rs 3,757.95 crore in the second quarter of financial year 08, from Rs 3,544.62 crore in the same period last fiscal.
Exide net up 25% at Rs 78 cr
Storage battery maker Exide Industries Ltd said its net profit has increased by 25% cent at Rs 78 crore for the second quarter ended September 30 compared with the corresponding period last year.
The company reported a net sales of Rs 901 crore, up 35%, it said in a statement today.
"Proactive steps taken during the last year to secure a portion of raw materials from secondary lead indigenously available by acquiring lead smelting capacities coupled with an improved sales mix has ensured satisfactory growth despite the very challenging economic environment," Exide MD and CEO T V...
More from Back Page
Discuss this story on expressindia forums
|
|
 |
 |
 |
About Us | Contact Us | Advertisers | Site Map | Make us your homepage | Work for Us | RSS | Subscribe | Electronic Edition | Privacy Policy© 2009: The Indian Express Limited. All rights reserved throughout the world
